Studies of variability in the islet amyloid polypeptide gene in relation to Type 2 diabetes
- 1 June 2003
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 20 (6) , 491-494
- https://doi.org/10.1046/j.1464-5491.2003.00951.x
Abstract
Aims To explore whether the coding region of the islet amyloid polypeptide (IAPP) gene contains genetic variants associated with Type 2 diabetes and whether a previously reported association of the promoter variant −132g→a with Type 2 diabetes could be reproduced in Danish Caucasians. Methods The coding region was analyzed using single strand conformation polymorphism (SSCP) and heteroduplex analysis in 192 Type 2 diabetic patients. Restriction fragment length polymorphism (RFLP) was employed to screen for the promoter variant in 414 Type 2 diabetic patients and 182 glucose‐tolerant control subjects. Results The SSCP analysis identified an IVS+75a→g variant in two patients. The frequency of heterozygous carriers of the promoter variant in the case–control study was 4.1% (17/414) and 7.1% (13/182), respectively. Odds ratio of the prevalence of Type 2 diabetes in carriers compared with non‐carriers was estimated to be 0.47 (95% confidence interval 0.19, 1.15). Conclusion Neither variability in the coding region of the IAPP gene nor the −132g→a promoter variant was associated with Type 2 diabetes among the studied Danish Caucasians. Diabet. Med. 20, 491–494 (2003)Keywords
This publication has 19 references indexed in Scilit:
- Studies of Genetic Variability of the Glucose Transporter 2 Promoter in Patients with Type 2 Diabetes MellitusJournal of Clinical Endocrinology & Metabolism, 2001
- S20G Mutant Amylin Exhibits Increased in Vitro Amyloidogenicity and Increased Intracellular Cytotoxicity Compared to Wild-Type AmylinThe American Journal of Pathology, 2000
- Deficiency of Total and Nonglycosylated Amylin in Plasma Characterizes Subjects with Impaired Glucose Tolerance and Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 2000
- Prevalence of Variants in Candidate Genes for Type 2 Diabetes Mellitus in The Netherlands: The Rotterdam Study and the Hoorn StudyJournal of Clinical Endocrinology & Metabolism, 1999
- Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing Type 2 (non-insulin-dependent) diabetes mellitusDiabetologia, 1992
- Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitusDiabetes Research and Clinical Practice, 1992
- Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitusDiabetes Research and Clinical Practice, 1992
- Islet amyloid polypeptide (amylin): no evidence of an abnormal precursor sequence in 25 Type 2 (non-insulin-dependent) diabetic patientsDiabetologia, 1990
- Islet amyloid polypeptide in diabetic and non-diabetic Pima IndiansDiabetologia, 1990
- Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitroNature, 1988